CSPC Pharmaceutical Group Limited (CVG) — Cash Flow Quality Index
CSPC Pharmaceutical Group Limited (CVG) has a Cash Flow Quality Index of 1.79x as of September 2020. Operating cash flow of €2.16 Billion exceeds net income of €1.20 Billion, indicating high earnings quality where cash backs reported profits. Explore CSPC Pharmaceutical Group Limited (CVG) cash conversion ratio to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
CSPC Pharmaceutical Group Limited Cash Flow Quality Index (2013–2025)
Historical Cash Flow Quality Index for CSPC Pharmaceutical Group Limited across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check CSPC Pharmaceutical Group Limited (CVG) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for CSPC Pharmaceutical Group Limited (2013–2025)
Year-by-year earnings quality comparison for CSPC Pharmaceutical Group Limited. For live market cap and the full company financial profile, see CSPC Pharmaceutical Group Limited (CVG) market capitalisation.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.50x | €5.83 Billion | €3.88 Billion | ▲ +53.4% |
| 2024 | 0.98x | €4.53 Billion | €4.63 Billion | ▲ +49.5% |
| 2023 | 0.65x | €4.18 Billion | €6.38 Billion | ▼ -40.3% |
| 2022 | 1.10x | €7.63 Billion | €6.95 Billion | ▲ +63.4% |
| 2021 | 0.67x | €4.64 Billion | €6.90 Billion | ▼ -38.6% |
| 2020 | 1.09x | €6.74 Billion | €6.16 Billion | ▲ +7.4% |
| 2019 | 1.02x | €3.78 Billion | €3.71 Billion | ▼ -17.3% |
| 2018 | 1.23x | €3.80 Billion | €3.08 Billion | ▲ +3.8% |
| 2017 | 1.19x | €3.29 Billion | €2.77 Billion | ▼ -23.4% |
| 2016 | 1.55x | €2.92 Billion | €1.88 Billion | ▲ +14.8% |
| 2015 | 1.35x | €2.25 Billion | €1.67 Billion | ▼ -5.2% |
| 2014 | 1.42x | €1.81 Billion | €1.27 Billion | ▲ +70.0% |
| 2013 | 0.84x | €814.86 Million | €972.75 Million | — |